Showing 1 - 20 results of 26 for search 'N JAIN', 查询时间: 0.04s Refine Results
  1. 1
    Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer

    Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast canc... 由 V. Sekhri, N. Jain, S. Kapoor

    出版 2024-02-01
    获取全文
    文件
  2. 2
    VON RECKLINGHAUSEN'S DISEASE

    VON RECKLINGHAUSEN'S DISEASE 由 Salamat Khan, A Chandra, N Jain, A Kumar, I U Khan

    出版 2004-07-01
    获取全文
    文件
  3. 3
    PB1883: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINOTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS INDUCES DEEP REMISSIONS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL.

    PB1883: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINOTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS INDUCES DEEP REMISSIONS: EARLY RESULTS OF AN ONGOING PH... 由 J. Burger, M. Sivina, E. Kim, G. Issa, W. Wierda, N. Jain, P. Thompson, A. Ferrajoli

    出版 2022-06-01
    获取全文
    文件
  4. 4
    Efficacy of Oral Hygiene Aids in Gingivitis Management: A Comparative Study of Manual and Electric Toothbrushes, Dental Floss, and Mouthwash

    Efficacy of Oral Hygiene Aids in Gingivitis Management: A Comparative Study of Manual and Electric Toothbrushes, Dental Floss, and Mouthwash 由 Civy V. Pulayath, Fathimath Al Zahrath, Ajith A. Chandy, Harish Chandran, Shanthi Menezes, Harshvardhan N. Jain

    出版 2024-12-01
    获取全文
    文件
  5. 5
    P651: VENETOCLAX-BASED TREATMENT OF PATIENTS WITH RICHTER SYNDROME: OUTCOMES FROM A MULTICENTER RETROSPECTIVE STUDY

    P651: VENETOCLAX-BASED TREATMENT OF PATIENTS WITH RICHTER SYNDROME: OUTCOMES FROM A MULTICENTER RETROSPECTIVE STUDY 由 P. Hampel, S. Parikh, W. Wierda, A. Ferrajoli, N. Jain, J. Burger, T. Call, Y. Wang, S. Kenderian, W. Ding, P. Thompson

    出版 2022-06-01
    获取全文
    文件
  6. 6
    Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review

    Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review 由 Rahul S. Tade, Swapnil N. Jain, Janhavi T. Satyavijay, Pratham N. Shah, Tejaswi D. Bari, Tanushri M. Patil, Ruhi P. Shah

    出版 2024-03-01
    获取全文
    文件
  7. 7
    P670: ABSENCE OF BTK, BCL2, AND PLCG2 MUTATIONS IN RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER FIRST-LINE TREATMENT WITH FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V)

    P670: ABSENCE OF BTK, BCL2, AND PLCG2 MUTATIONS IN RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER FIRST-LINE TREATMENT WITH FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) 由 L. J. Croner, J. N. Allan, N. Jain, J. F. Seymour, K. Eckert, L. W. K. Cheung, E. Szafer-Glusman

    出版 2022-06-01
    获取全文
    文件
  8. 8
    Role of chest radiograph in predicting the need for ventilator support in COVID‐19 patients

    Role of chest radiograph in predicting the need for ventilator support in COVID‐19 patients 由 G Patnayak, R Rastogi, L Khajuria, A Mohan, N Jain, R Varshney, V K Singh, V Patrap, S Pathak, A Jain, K Duggad

    出版 2022-12-01
    获取全文
    文件
  9. 9
    P310: BH3 PROFILING IDENTIFIES SELECTIVE BCL-2 DEPENDENCE OF ADULT EARLY T-CCELL PROGENITOR AND TYPICAL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

    P310: BH3 PROFILING IDENTIFIES SELECTIVE BCL-2 DEPENDENCE OF ADULT EARLY T-CCELL PROGENITOR AND TYPICAL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 由 K. Bhatia, A. Mahesh, E. Olesinski, J. Garcia, N. Jain, W. Y. Jen, M. Ooi Gaik Ming, A. Letai, M. Konopleva, S. Bhatt

    出版 2022-06-01
    获取全文
    文件
  10. 10
    P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL

    P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTOR... 由 N. Jain, G. Roboz, M. Konopleva, H. Liu, G. Schiller, E. Jabbour, P. Desai, D. Whitfield, A. Haider, O. Zernovak, M. Frattini, C. Brownstein, R. Larson

    出版 2022-06-01
    获取全文
    文件
  11. 11
    P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)

    P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) 由 T. Kadia, F. Ravandi, G. Borthakur, E. Jabbour, G. Montalban-Bravo, L. Adewale, S. Pierce, C. Lacke, M. Brandt, N. Short, N. Jain, J. Burger, A. Ferrajoli, W. Wierda, H. Kantarjian

    出版 2022-06-01
    获取全文
    文件
  12. 12
    P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB

    P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB 由 W. Macaron, E. Jabbour, M. Konopleva, F. Ravandi, N. Jain, G. Issa, T. Kadia, K. Sasaki, P. Kebriaei, M. Yilmaz, P. Thompson, K. Takahashi, H. Abbas, W. Wierda, R. Garris, H. Kantarjian, N. Short

    出版 2022-06-01
    获取全文
    文件
  13. 13
    P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA 由 J. Senapati, E. J. Jabbour, N. J. Short, F. Ravandi, P. Kebriaei, T. M. Kadia, G. Borthakur, N. Pemmaraju, R. S. Garris, D. Bansal, S. Konoplev, S. Wang, W. Wang, G. Tang, K. P. Patel, M. Konopleva, N. Jain

    出版 2022-06-01
    获取全文
    文件
  14. 14
    P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS

    P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS 由 S. Venugopal, E. Jabbour, N. Pemmaraju, G. Montalban-Bravo, K. S. Chien, N. Daver, N. Jain, J. Burger, Y. Alvarado, A. Maiti, C. D. DiNardo, G. Borthakur, R. Malla, G. Garcia-Manero, F. Ravandi, H. Kantarjian, T. Kadia

    出版 2022-06-01
    获取全文
    文件
  15. 15
    P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY

    P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS... 由 T. Abuasab, Y. Alvarado, G. Issa, R. Islam, N. Short, M. Yilmaz, N. jain, L. Masarova, S. Kornblau, E. Jabbour, N. Pemmaraju, G. Montalban-Bravo, S. Pierce, C. DiNardo, T. Kadia, N. Daver, M. Konopleva, G. Garcia-Manero, F. Ravandi

    出版 2022-06-01
    获取全文
    文件
  16. 16
    P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)

    P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBL... 由 F. Ravandi, E. Jabbour, N. Jain, T. Kadia, B. Gautam, M. Konopleva, W. Wierda, J. Burger, G. Issa, A. Maiti, H. Balkin, M. Kelly, R. Garris, P. Kebriaei, A. Ferrajoli, G. Garcia-Manero, Y. Alvarado, N. Short, H. Kantarjian

    出版 2022-06-01
    获取全文
    文件
  17. 17
    P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WITHOUT BLINATUMOMAB, IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATES FROM A PHASE II TRIAL

    P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WITHOUT BLINATUMOMAB, IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATES FROM A PHASE II TRI... 由 F. Haddad, H. Kantarjian, N. Short, F. Ravandi, N. Jain, W. Macaron, T. Kadia, Y. Alvarado, N. Daver, G. Borthakur, C. DiNardo, M. Konopleva, W. Wierda, J. Jacob, E. Roy, C. Loiselle, A. Milton, J. Rivera, R. Garris, E. Jabbour

    出版 2022-06-01
    获取全文
    文件
  18. 18
    P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA 由 J. Senapati, H. Kantarjian, N. Short, Y. Alvarado, J. Burger, N. Jain, M. Konopleva, F. Ravandi, C. DiNardo, L. Masarova, K. Sasaki, P. A. Thompson, A. Ferrajoli, J. O. Jacob, E. D. Mayor, A. M. Milton, C. Loiselle, R. S. Garris, E. J. Jabbour

    出版 2022-06-01
    获取全文
    文件
  19. 19
    P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

    P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA 由 J. Senapati, H. Kantarjian, N. Short, M. Konopleva, F. Ravandi, N. Jain, P. A. Thompson, N. Pemmaraju, W. G. Wierda, G. Borthakur, T. M. Kadia, G. Garcia-Manero, M. Yilmaz, J. Thankachan, M. Zhao, C. Loiselle, M. T. Talley, M. I. Kwari, R. S. Garris, E. J. Jabbour

    出版 2022-06-01
    获取全文
    文件
  20. 20
    P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEU... 由 N. Short, H. Kantarjian, F. Ravandi, M. Yilmaz, T. Kadia, P. Thompson, X. Huang, M. Konopleva, A. Ferrajoli, N. Jain, K. Sasaki, Y. Alvarado, G. Borthakur, C. Dinardo, M. Ohanian, W. Macaron, S. Kornblau, M. Zhao, M. Kwari, C. Loiselle, R. Delumpa, A. Milton, J. Rivera, S. Lewis, R. Garris, E. Jabbour

    出版 2022-06-01
    获取全文
    文件

检索工具: